Gault Judith, Awad Issam A, Recksiek Peter, Shenkar Robert, Breeze Robert, Handler Michael, Kleinschmidt-DeMasters Bette K
Department of Neurosurgery, University of Colorado, Denver, Aurora, Colorado, USA.
Neurosurgery. 2009 Jul;65(1):138-44; discussion 144-5. doi: 10.1227/01.NEU.0000348049.81121.C1.
Germline mutations in 3 genes have been found in familial cases of cerebral cavernous malformations (CCMs). We previously discovered somatic and germline truncating mutations in the KRIT1 gene, supporting the "2-hit" mechanism of CCM lesion formation in a single lesion. The purpose of this study was to screen for somatic, nonheritable mutations in 3 more lesions from different patients and identify the cell type(s) in which somatic mutations occur.
Somatic mutations were sought in DNA from 3 surgically excised, fresh-frozen CCM lesions by cloning and screening polymerase chain reaction products generated from KRIT1 or PDCD10 coding regions. Laser capture microdissection was used on isolated endothelial and nonendothelial cells to determine whether somatic mutations were found in endothelial cells.
CCM lesions harbor somatic and germline KRIT1 mutations on different chromosomes and are therefore biallelic. Both mutations are predicted to truncate the protein. The KRIT1 somatic mutations (novel c.1800delG mutation and previously identified 34 nucleotide deletion) in CCMs from 2 different patients were found only in the vascular endothelial cells lining caverns. No obvious somatic mutations were identified in the 2 other lesions; however, the results were inconclusive, possibly owing to the technical limitations or the fact that these specimens had a small proportion of vascular endothelial cells lining pristine caverns.
The "2-hit" mechanism occurs in vascular endothelial cells lining CCM caverns from 2 patients with somatic and Hispanic-American KRIT1 germline mutations. Methods for somatic mutation detection should focus on vascular endothelial cells lining pristine caverns.
在家族性脑海绵状血管畸形(CCM)病例中发现了3个基因的种系突变。我们之前在KRIT1基因中发现了体细胞和种系截短突变,支持单个病变中CCM病变形成的“二次打击”机制。本研究的目的是筛查来自不同患者的另外3个病变中的体细胞非遗传性突变,并确定发生体细胞突变的细胞类型。
通过克隆和筛选从KRIT1或PDCD10编码区产生的聚合酶链反应产物,在3个手术切除的新鲜冷冻CCM病变的DNA中寻找体细胞突变。对分离的内皮细胞和非内皮细胞进行激光捕获显微切割,以确定在内皮细胞中是否发现体细胞突变。
CCM病变在不同染色体上存在体细胞和种系KRIT1突变,因此是双等位基因的。两种突变均预计会截断蛋白质。在来自2名不同患者的CCM中,KRIT1体细胞突变(新的c.1800delG突变和先前鉴定的34个核苷酸缺失)仅在海绵状血管内皮细胞中发现。在另外2个病变中未发现明显的体细胞突变;然而,结果尚无定论,可能是由于技术限制或这些标本中原始海绵状血管内皮细胞比例较小。
“二次打击”机制发生在2名患有体细胞和西班牙裔美国人种系KRIT1突变的患者的CCM海绵状血管内皮细胞中。体细胞突变检测方法应集中在原始海绵状血管内皮细胞上。